Hongruo Yun

Title: Innovations by Inventor Hongruo Yun

Introduction

Hongruo Yun is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of biomedical engineering, particularly in the development of constructs for targeted therapies. With a total of 4 patents, his work focuses on innovative solutions for cancer treatment.

Latest Patents

One of his latest patents is titled "Constructs targeting prostate-specific membrane antigen (PSMA) and uses thereof." This application provides constructs that include an antibody moiety specifically binding to PSMA, which is expressed on the surface of certain cells. The patent also outlines methods for making and utilizing these constructs effectively. Another notable patent is "Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereof." This application describes immune cells, such as T cells, that incorporate a chimeric antibody-T cell receptor construct and a chimeric signaling receptor construct. These innovations aim to enhance the immune response against targeted antigens.

Career Highlights

Hongruo Yun is currently associated with Eureka Therapeutics, Inc., where he continues to advance his research and development efforts. His work has been instrumental in creating novel therapeutic approaches that leverage the immune system to combat cancer.

Collaborations

He collaborates with notable colleagues, including Hong Liu and Pengbo Zhang, to further enhance the impact of their research in the field.

Conclusion

Hongruo Yun's innovative contributions to targeted cancer therapies exemplify the potential of biomedical engineering to transform treatment options. His patents reflect a commitment to advancing medical science and improving patient outcomes.